Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

MoonLake Immunotherapeutics

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21
   10-K10-K
Revenues  0.00.0
Cost of goods sold  0.00.0
Gross profit  0.00.0
Selling, general and administrative   [+]23.04.6
Research and development  42.0 
EBITDA   [+]-65.0 
Depreciation and amortization  0.0 
EBIT   [+]-65.1-4.6
Interest income   0.0
Other income (expense), net  0.6 
Pre-tax income  -64.5-4.5
Income taxes  0.00.0
            Tax rate  0.1%0.0%
Minority interest  -14.5 
Net income  -49.9-4.5
   
Basic EPS   [+]($1.70)($0.38)
Diluted EPS   [+]($1.70)($0.01)
   
Shares outstanding (basic)   [+]29.411.9
Shares outstanding (diluted)   [+]29.4360.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy